glp 1 dry mouth GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects With nearly 40 million Americans
Description
GIP (glucose-dependent insulinotropic polypeptide) enhances insulin sensitivity and nutrient processing, while GLP-1 slows gastric emptying and signals satiety to your brain
And a study published in January 2025 suggested that popular GLP-1 medications approved for weight loss, diabetes and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections and some kinds of cancer and dementia
Peaka GLP-1 is a dietary supplement, not an FDA-approved medication
Immune system: Autoimmune diseases involve immune-driven inflammation (e.g., T-cell activation and autoantibodies), which differs from metabolic stress pathways
